Popliteal Aneurysm Clinical Trial
— VAP-AURCOfficial title:
Treatment of Popliteal Aneurysms With VIABAHN Stent Graft in Elective Surgery: Multicenter Prospective Registry of the Research in Vascular Surgery University Association (AURC)
This multicentric, prospective study will evaluate the medium-term outcomes of patients implanted with GORE VIABAHN® stent grafts for popliteal artery aneurysms in scheduled elective surgery with the registry of the Research in Vascular Surgery University Association (AURC)
Status | Not yet recruiting |
Enrollment | 50 |
Est. completion date | September 2022 |
Est. primary completion date | September 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - > 18 years old at time of treatment - symptomatic or asymptomatic popliteal artery aneurysm needing surgery - scheduled elective surgery Exclusion Criteria: - life expectancy of <1 year - thrombotic occlusion of popliteal artery - intolerance to antiplatelet drugs (antiaggregants) - known allergies to GORE VIABAHNĀ® stent graft materials/composition - emergency surgery |
Country | Name | City | State |
---|---|---|---|
France | Hôpital pneumologique et cardiovasculaire Louis Pradel (HCL) | Bron |
Lead Sponsor | Collaborator |
---|---|
Hospices Civils de Lyon |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Major limb events | Composite criterion associating Target Lesion Revascularization (TLR) and Rate of major amputation. An Echo-Doppler imaging examination will be performed and the following parameters and information should be collected: Permeability Intra-stent restenosis Systolic pressure index |
2 years of follow-up |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04907240 -
Observational GORE® VIABAHN® Endoprosthesis With PROPATEN Bioactive Surface Global Registry
|